|Articles|January 27, 2010

Delirium

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Metabolic & Mental Health: A Conversation With Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD

ByJessica M. Gannon, MD,Benjamin I. Perry, PhD,Nicolette Stogios, PhD,Katharine Liang, MD, PhD

July 9th 2026

Podcast: A Transdiagnostic Approach to Metabolic Health and Mental Illness

ByJessica M. Gannon, MD,Benjamin I. Perry, PhD,Nicolette Stogios, PhD,Katharine Liang, MD, PhD

July 9th 2026

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

BySophia Hashmi,Hazem Shahin, MD

June 24th 2026

Addressing Sexual Wellness: A Psychiatric Perspective

ByGrace L. Johnson, MD,Alex Rains, MD,Renee Sorrentino, MD

June 11th 2026

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

ByMasha Impallaria, MD,Caitlin Leconte, MD,Irina Matsneva, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

May 11th 2026

Latest CME

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Delirium

Delirium

Related Content

Metabolic & Mental Health: A Conversation With Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD

Podcast: A Transdiagnostic Approach to Metabolic Health and Mental Illness

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

Addressing Sexual Wellness: A Psychiatric Perspective

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

Latest CME

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Positive Safety and Biomarker Phase 1b Results for PMN310 Mild Cognitive Impairment and Alzheimer Disease

Attachment-Based Therapy in Adolescent Substance Users: A Meta-Synthesis of Emotional Isolation and Avoidant Attachment Patterns

Can Psychiatry Lead in Building Brain Capital? Why Mental Health Matters for Policy, Economy, and Society

Categories vs Dimensions: Wave or Particle?

Novel CSF Biomarker and Peptide Candidate Target Cognitive Symptoms of Schizophrenia